# The Comparative Clinical Study of Gamisoyosan on Anxiety of Generalized Anxiety Disorder According to Dosage Form

> **NCT01285115** · PHASE3 · COMPLETED · sponsor: **Korea Health Industry Development Institute** · enrollment: 147 (actual)

## Conditions studied

- Generalized Anxiety Disorder

## Interventions

- **DRUG:** Placebo
- **DRUG:** KyungBangn-Gamisoyosan-x-gwarip
- **DRUG:** KyungBangn Gamisoyosan

## Key facts

- **NCT ID:** NCT01285115
- **Lead sponsor:** Korea Health Industry Development Institute
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2010-06
- **Final completion:** 2010-07
- **Target enrollment:** 147 (ACTUAL)
- **Last updated:** 2011-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01285115

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01285115, "The Comparative Clinical Study of Gamisoyosan on Anxiety of Generalized Anxiety Disorder According to Dosage Form". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01285115. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*